Insulin aspart, recombinant Subcutaneous and MPI DTPA
Determining the interaction of Insulin aspart, recombinant Subcutaneous and MPI DTPA and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pentetate calcium trisodium
Brand name:
Synonyms: Pentetate, Pentetate Calcium Trisodium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-MS Contin
- Insulin aspart, recombinant Subcutaneous-MST
- Insulin aspart, recombinant Subcutaneous-MTX Support
- Insulin aspart, recombinant Subcutaneous-MucaphEd
- Insulin aspart, recombinant Subcutaneous-Mucinex Allergy
- Insulin aspart, recombinant Subcutaneous-Mucinex Cough Mini-Melts
- MPI DTPA-Insulin degludec
- MPI DTPA-Insulin Degludec (U-100) Prefilled Pens
- MPI DTPA-Insulin Degludec (U-100) Vials
- MPI DTPA-Insulin Degludec (U-200) Prefilled Pens
- MPI DTPA-Insulin degludec and liraglutide
- MPI DTPA-Insulin degludec and liraglutide Subcutaneous